Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2B | Q13224 | 16/20 | 0.48 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.45 |
| ▸ | VNN1 | O95497 | 1/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.38 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5353035 | 0.92 | GRIN2B (0.45) | GRIN2BSIGMAR1VNN1 | |
| SCHEMBL5347607 | 0.92 | GRIN2B (0.50) | GRIN2BSIGMAR1 | |
| SCHEMBL5347603 | 0.92 | GRIN2B (0.50) | GRIN2BSIGMAR1 | |
| SCHEMBL14502229 | 0.92 | GRIN2B (0.50) | GRIN2BSIGMAR1 | |
| SCHEMBL5345770 | 0.90 | GRIN2B (0.50) | GRIN2BSIGMAR1VNN1CYP11B2 | |
| SCHEMBL5356894 | 0.89 | GRIN2B (0.47) | GRIN2BSIGMAR1VNN1 | |
| SCHEMBL14502243 | 0.89 | GRIN2B (0.44) | GRIN2BSIGMAR1CYP11B2 | |
| SCHEMBL5366625 | 0.89 | GRIN2B (0.44) | GRIN2BSIGMAR1CYP11B2 | |
| SCHEMBL5366136 | 0.86 | GRIN2B (0.48) | GRIN2BSIGMAR1 | |
| SCHEMBL5778248 | 0.86 | SIGMAR1 (0.51) | GRIN2BSIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7217716-B2 | N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists | MERCK & CO., INC. (US) | 2007-05-15 | — | — | US | disclosed |
| US-7217716-B2 | N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists | MERCK & CO., INC. (US) | 2007-05-15 | — | — | US | disclosed |
| US-7217716-B2 | N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists | MERCK & CO., INC. (US) | 2007-05-15 | — | — | US | disclosed |
| EP-1379520-B1 | N-SUBSTITUTED NONARYL-HETEROCYCLIC NMDA/NR2B ANTAGONISTS | MERCK & CO INC (US) | 2006-04-26 | — | — | EP | disclosed |